Results
1
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨125.4b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨393.75
7D
-1.2%
1Y
29.8%